Call 14 of the Innovative Medicines Initiative (IMI) is now open with topics on immune diseases, imaging, machine learning and digital clinical trials

The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry.

Call ID:   H2020-JTI-IMI2-2018-14-two-stage

Topics

• Topic 1: Targeted immune intervention for the management of non-response and relapse

• Topic 2: Non-invasive clinical molecular imaging of immune cells

• Topic 3: Development of a platform for federated and privacy-preserving machine learning in support of drug discovery

• Topic 4: Centre of excellence – remote decentralised clinical trials

Stage 1 submission deadline: 14 June 2018

Read on: https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-14